Kimia Pharmaceutical

Kimia Pharmaceutical

Silver membership

Kimia Pharmaceutical

Group : Pharmaceutical & Health

Company work : The production of high-risk drugs(Anticancer drugs)

Main products : Imatinib Kitent (Sunitinib) Kimotar (Erlotinib) Soranex(Sorafenib) Kimoniَl(Nilotinib)

Novavaran Pharmaceuticals Kimia (Joint Stock) in 2010 with the participation of a number of university professors and specialists in the country's pharmaceutical industry with the aim of creating technical know-how and production of new drugs introduced to the world drug market. The company, including Knowledge Foundation Based in the center of growth of pharmaceutical technology units and Bu'ali National Biotechnology Park, Tehran University of Medical Sciences.

The creation of technical knowledge of pharmaceutical raw materials, the formulation and production of high-risk drugs and special products have been on the agenda since its inception. During the past six years, the company has been able to step through the use of the expertise of domestic experts and the use of trained, innovative and young forces. Has taken a long time to promote the pharmaceutical industry of the country

Products / Services

Kimonil capsule 200 mg -

Kimonil capsule 200 mg

Packaging : The can of 30 hard capsules

kitent capsule 12.5 ml -

kitent capsule 12.5 ml

Packaging : The can of 30 hard capsules

Kitent capsule 50 mg -

Kitent capsule 50 mg

Packaging : The can of 30 hard capsules

kitent capsule25 ml -

kitent capsule25 ml

Packaging : The can of 30 hard capsules

Imatinib capsule 100 mg -

Imatinib capsule 100 mg

Packaging : The can of 30 hard capsules

Contact Details

CEO : Ismail Moazeni
Website :http://kimia-pharma.co
Email :
Tell phone: +982188012946
Fax :+982188013271
Address: No. 1462, North Kargar Street, North of Tehran University, Tehran, Iran

Send Message


Last seen
Scroll to top